摘要
目的:探讨ZKSCAN3(zinc finger with KRAB and SCAN domains 3)在乳腺癌组织中的表达及其临床意义。方法 :应用免疫组织化学法检测120例乳腺癌组织及60例癌旁组织中ZKSCAN3蛋白的表达,并分析其与患者临床病理参数和总生存率之间的关系。进一步应用实时荧光定量PCR法和蛋白质印迹法检测乳腺癌组织及其相应癌旁组织中ZKSCAN3 m RNA和蛋白的表达水平。结果:乳腺癌组织中ZKSCAN3蛋白的阳性表达率[74%(89/120)]高于相应的癌旁组织[37%(22/60)](P<0.001)。ZKSCAN3蛋白的表达与乳腺癌患者肿块大小、淋巴结转移、分化程度和肿瘤分期相关(P值均<0.05),ZKSCAN3阳性表达患者的总生存率明显低于阴性患者(P=0.040)。乳腺癌组织中ZKSCAN3 m RNA和蛋白的表达水平均高于癌旁组织(P值均<0.01)。结论 :ZKSCAN3与乳腺癌的发生、进展及转移有关,可能是乳腺癌的促癌基因。
Objective: To investigate the expression of zinc finger with KRAB and SCAN domains 3(ZKSCAN3) in breast cancer tissues and its clinical significance.Methods: The expression of ZKSCAN3 in 120 specimens of human breast cancer tissues and 60 specimens of adjacent para-cancerous tissues was detected by immunohistochemistry, and its correlation with clinicopathological parameters and overall survival was analyzed. The real-time fluorescent quantitative PCR and Western blotting were used to further detect the expressions of ZKSCAN3 m RNA and proteinin breast cancer tissues and the adjacent para-cancerous tissues.Results: The positive expression rate of ZKSCAN3 protein in breast cancer tissues [74%(89/120)] was higher than that in the adjacent para-cancerous tissues [37%(22/60)](P 〈0.001). The expression of ZKSCAN3 protein was correlated with tumor size, lymph node metastasis, tumor differentiation and clinical stage of breast cancer(all P 〈0.05). The overall survival rate of patient with ZKSCAN3-positive breast cancer was significantly lower than that of patient with ZKSCAN3-negative breast cancer(P = 0.040). The expression levels of ZKSCAN3 m RNA and protein in breast cancer tissues were higher than those in the adjacent para-cancerous tissues(both P〈 0.01).Conclusion: ZKSCAN 3 is associated with the occurrence, progression and metastasis of breast cancer, so it may be an oncogene of breast cancer.
出处
《肿瘤》
CAS
CSCD
北大核心
2017年第9期960-966,共7页
Tumor